A 2009 study published in Endocrine Reviews found that melanocortin receptor agonists produce dramatically different clinical profiles depending on which receptor subtypes they activate
According to NBC News, the third phase of the clinical trial found that people with osteoarthritis who dieted, exercised, and took semaglutide the blockbuster drug sold by Novo Nordisk as Ozempic and Wegovy lost more weight and reported a greater reduction in knee pain than those who lost weight with just diet and exercise. The study included roughly 400 patients with knee osteoarthritis, 80% being women, who experience osteoarthritis at higher rates than men, according to NBC News
Beyond migraine prevention, magnesium helps with the constipation that GLP-1 drugs can cause
For the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R), a mean slope of 1.0 was observed in the treated group compared to 1.4 in the untreated patients ( p = 0.0575)
Interestingly, we did not observe group differences in glycemic or lipid parameters when stratified by epigenetic age change following semaglutide
Funding Ministry of Education, RS-2023-00245453, Ji-Hun Jang and Seung-Hyun Jeong